IRIS
DI MUZIO, NADIA GISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.383
AS - Asia 5.142
NA - Nord America 3.946
SA - Sud America 1.392
Continente sconosciuto - Info sul continente non disponibili 324
AF - Africa 141
OC - Oceania 13
AN - Antartide 1
Totale 16.342
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.721
RU - Federazione Russa 2.879
SG - Singapore 1.897
CN - Cina 1.535
BR - Brasile 1.138
IT - Italia 699
HK - Hong Kong 650
SE - Svezia 608
VN - Vietnam 514
RO - Romania 266
FR - Francia 256
DE - Germania 173
BD - Bangladesh 143
CA - Canada 94
AR - Argentina 93
GB - Regno Unito 90
FI - Finlandia 85
IN - India 80
ES - Italia 79
MX - Messico 64
ZA - Sudafrica 51
NL - Olanda 49
ID - Indonesia 45
EC - Ecuador 44
AT - Austria 38
CO - Colombia 37
IE - Irlanda 36
IQ - Iraq 35
TR - Turchia 35
UA - Ucraina 32
JP - Giappone 26
PL - Polonia 25
PY - Paraguay 25
UZ - Uzbekistan 21
SA - Arabia Saudita 19
JM - Giamaica 17
MA - Marocco 17
MY - Malesia 16
PE - Perù 16
PK - Pakistan 16
CR - Costa Rica 14
EG - Egitto 14
KE - Kenya 14
PH - Filippine 14
CL - Cile 13
TN - Tunisia 13
VE - Venezuela 12
NP - Nepal 11
AU - Australia 10
JO - Giordania 10
TT - Trinidad e Tobago 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
IR - Iran 9
TH - Thailandia 9
DZ - Algeria 8
UY - Uruguay 8
EU - Europa 7
LT - Lituania 7
MD - Moldavia 7
PT - Portogallo 7
SV - El Salvador 7
TW - Taiwan 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
MK - Macedonia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
BO - Bolivia 4
CG - Congo 4
CH - Svizzera 4
DK - Danimarca 4
KR - Corea 4
LB - Libano 4
CZ - Repubblica Ceca 3
GR - Grecia 3
HN - Honduras 3
NZ - Nuova Zelanda 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SC - Seychelles 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MN - Mongolia 2
NO - Norvegia 2
QA - Qatar 2
RS - Serbia 2
SR - Suriname 2
Totale 16.004
Salva come PNG Salva come JPEG
Città #
Singapore 861
Moscow 655
Hong Kong 635
Dallas 566
Ashburn 525
San Jose 396
Council Bluffs 322
Shanghai 322
Hefei 244
Beijing 226
Lauterbourg 223
Lawrence 204
Princeton 202
Milan 182
Ho Chi Minh City 181
New York 149
Hanoi 128
São Paulo 89
Santa Clara 88
Los Angeles 87
Rome 66
Helsinki 58
Munich 51
Valencia 44
Nuremberg 41
Orem 35
Dublin 33
Brooklyn 32
Naples 32
Rio de Janeiro 32
Boardman 30
Belo Horizonte 27
Omaha 27
Chicago 26
Da Nang 25
Johannesburg 25
Denver 24
Chennai 23
Montreal 23
Brasília 22
Guangzhou 22
Tokyo 21
Mexico City 20
Guayaquil 19
Bologna 18
Curitiba 18
Boston 17
Frankfurt am Main 17
Haiphong 17
Manchester 17
Phoenix 17
Tashkent 17
Toronto 17
Warsaw 17
Washington 17
Amsterdam 16
London 16
Seattle 16
Biên Hòa 15
Can Tho 15
Poplar 15
Atlanta 14
Buffalo 14
Figino 14
Shenzhen 14
Stockholm 14
Charlotte 13
Houston 13
Porto Alegre 13
San José 13
Thái Bình 13
Vienna 13
Dhaka 12
Genoa 12
Lappeenranta 12
Mumbai 12
Pune 12
Quito 12
Baghdad 11
Bogotá 11
Cape Town 11
Fortaleza 11
Goiânia 11
Ipatinga 11
St Louis 11
Ankara 10
Campinas 10
Las Vegas 10
Manaus 10
Osasco 10
Salvador 10
Tampa 10
The Dalles 10
Amman 9
Duque de Caxias 9
Hangzhou 9
Juiz de Fora 9
Lima 9
Nairobi 9
Querétaro 9
Totale 7.765
Salva come PNG Salva come JPEG
Nome #
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer 335
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 232
Health-related quality of life 24 months after prostate cancer diagnosis: An update from the Pros-IT CNR prospective observational study 205
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 188
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 173
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats 167
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 165
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 150
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 144
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 142
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 140
A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer 138
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 138
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 134
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 132
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells 125
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 123
Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index 122
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 121
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 121
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study 121
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 119
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 118
A Case of Radiotherapy During Pregnancy for Oropharyngeal Cancer: Long-Term Pediatric Outcome Evaluation and Literature Review 117
Patients with Cardiac Implantable Electronic Device Undergoing Radiation Therapy: Insights from a Ten-Year Tertiary Center Experience 113
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 113
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 109
Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review 107
Predictors of patient-reported incontinence at adjuvant/salvage radiotherapy after prostatectomy: Impact of time between surgery and radiotherapy 105
A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer 104
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 101
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers 99
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 99
Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy 99
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 98
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 95
Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016 93
Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review 88
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 88
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 87
La qualità della vita del paziente col tumore alla prostata sottoposto a trattamento radioterapico: uno studio prospettico 83
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 83
Ocular leukemic mass-like relapse treated with CyberKnife stereotactic radiosurgery 82
Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy 81
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 81
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 80
Repeat gamma knife radiosurgery for recurrent pituitary adenomas. 80
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 80
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration 79
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation 78
Quality indicators in the intensity modulated/image-guided radiotherapy era 76
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 75
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 75
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 75
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 74
Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges 74
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience 73
Pros-IT CNR: an Italian prostate cancer monitoring project 72
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: A single-institute analysis of 742 patients 71
Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas 71
Knowledge-based automatic optimization of adaptive early-regression-guided VMAT for rectal cancer 71
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. 70
Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? 70
More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis 70
Modelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapy 68
Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 68
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 68
Knowledge-based automatic plan optimization for left-sided whole breast tomotherapy 67
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 67
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy 66
Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation 66
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases 66
Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial 65
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 65
Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters 65
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 65
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized? 65
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 65
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT 64
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy 64
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 64
Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients 64
Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer 63
Segmentation of FDG PET lung lesions based on a thresholding approach for BTV definition 63
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison 63
Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy 63
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 63
Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: The impact of competing causes of mortality and patient stratification 62
Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma. 62
La qualità di vita del paziente con tumore alla prostata sottoposto a trattamento radioterapico 62
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases 62
Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC 62
Hematologic Toxicity in Patients Treated With Postprostatectomy Whole-Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study 62
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak 62
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 62
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy 61
Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study 61
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy 61
Characterization of volume and shape modifications of PET-positive nodes during Tomotherapy for head and neck cancer as assessed by MVCTs 61
Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design 61
Totale 9.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022145 0 0 2 88 4 7 10 8 12 6 1 7
2022/20231.108 472 233 75 6 0 117 42 77 46 5 11 24
2023/2024675 11 35 59 127 46 113 22 54 18 42 53 95
2024/20253.319 431 72 53 117 105 247 680 200 548 370 212 284
2025/20269.940 707 822 939 1.391 732 236 850 636 2.507 548 313 259
2026/2027962 473 489 0 0 0 0 0 0 0 0 0 0
Totale 16.342